Single-cell profiling and genetic regulation of alternative polyadenylation in the human brain
In the authors' words
Abstract Alternative polyadenylation (APA) has a central role in regulation of the fate of mRNA and exhibits high variability in the brain and in neurons. However, brain APA regulation has not been mapped at cell type resolution, and the genetic control of APA in brain cell types and its contribution to genetic disease have remained unclear. Here we report a single-cell atlas of APA of the aged human brain across 2 million cells from 379 human postmortem brains across individuals with and without Alzheimer’s disease (AD). We show that APA provides an independent mechanistic layer for understanding gene regulatory changes in AD, as genes with APA alterations are distinct from those with expression changes but often converge to similar pathways, including microglial activation and microtubule transport in neurons. We integrate APA variation with whole-genome sequencing to identify cell-type-resolved 3′ untranslated region quantitative trait loci (3′aQTLs) for 4,288 genes. We find that 3′aQTLs preferentially colocalize with pQTLs over eQTLs. Across 17 brain traits and diseases, we identify 168 GWAS loci dependent on 3′aQTLs, of which only 17.5% are shared with eQTLs. These include PLEKHA1 and APOC2 for AD, PAK6 and AP3B2 for schizophrenia, NDUFA13 for bipolar disorder, MTCH2 for multiple brain traits, and SNCA , the top locus in Parkinson’s disease. We show that 3′ untranslated region choice alters SNCA mRNA localization within the cell, consistent with the observation that the SNCA risk locus acts in an eQTL-independent manner in neurons and oligodendrocytes. Our results provide a cell-type-specific foundation to interrogate the cis and trans regulation of APA and to understand the contribution to disease heritability of this key post-transcriptional layer.
In plain words AI summary
The authors created a single-cell atlas of alternative polyadenylation (APA) in 2 million cells from 379 aged human brains, including people with and without Alzheimer's disease. APA changes in Alzheimer's disease involve different genes than expression changes, but both affect similar pathways like microglial activation and neuron transport. They found cell-type-specific genetic variants affecting APA for 4,288 genes, which more often affect protein levels than gene expression levels. Of 168 disease-related genetic loci linked to these APA variants, only 17.5% overlap with expression-related loci, including variants for Alzheimer's, schizophrenia, and Parkinson's disease. For Parkinson's disease gene SNCA, the APA variant changes where the mRNA sits in the cell, acting independently of expression changes.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.
Appeared: Friday, October 2. Nature Genetics. Peer-reviewed journal.